Basit öğe kaydını göster

dc.contributor.authorİnce, Nevin
dc.contributor.authorKaya, Şafak
dc.contributor.authorYıldız, İlknur Esen
dc.contributor.authorParlak, Emine
dc.contributor.authorBayar, Belkis
dc.date.accessioned2020-12-19T19:35:32Z
dc.date.available2020-12-19T19:35:32Z
dc.date.issued2020
dc.identifier.citationInce, N., Kaya, Ş., Esen Yıldız, İ., Parlak, E., & Bayar, B. (2020). Use of complementary and alternative medicine in patients with chronic viral hepatitis in Turkey. Complementary therapies in medicine, 48, 102229. https://doi.org/10.1016/j.ctim.2019.102229en_US
dc.identifier.issn0965-2299
dc.identifier.issn1873-6963
dc.identifier.urihttps://doi.org/10.1016/j.ctim.2019.102229
dc.identifier.urihttps://hdl.handle.net/11436/1308
dc.descriptionWOS: 000514023100014en_US
dc.descriptionPubMed: 31987221en_US
dc.description.abstractIntroduction: the global use of complementary and alternative medicine (CAM) is growing. the purpose of this study was to determine the prevalence of CAM use in patients in Turkey with CVH, the types of therapy, and patients' sociodemographic characteristics. Methods: the study was designed as a questionnaire-based, cross-sectional analysis. An infectious diseases outpatient follow-up questionnaire was administered to patients at face-to-face interviews. the data obtained were analyzed using SPSS 17 software. Results: This study included 588 patients, of whom 27% used CAM. No differences in sociodemographic characteristics were determined between patients using CAM and those not using it. Herbal methods were used by 63.6% of patients and cupping techniques by 25.4%. Education level was significantly correlated with herbal methods (p = 0.043). CAM use also increased in line with disease duration (p < 0.05). No difference in CAM use was determined between CHB patients using oral antiviral therapy and those not using it (p = 0.162). Conclusion: CAM use, particularly herbal products, is prevalent among Turkish adults with CVH. in case of use of herbal products in chronic viral hepatitis patients, toxicity and liver failure may develop as a result of herbal product-drug interactions. Physicians in the field of hepatology should, therefore, be aware of potential toxicity of CAM, especially in patients with chronic hepatitis liver diseases.en_US
dc.language.isoengen_US
dc.publisherChurchill Livingstoneen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic viral hepatitisen_US
dc.subjectComplemantary and Alternative Medicineen_US
dc.subjectPrevalenceen_US
dc.subjectAttitudeen_US
dc.subjectTurkeyen_US
dc.titleUse of complementary and alternative medicine in patients with chronic viral hepatitis in Turkeyen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorYıldız, İlknur Esen
dc.identifier.doi10.1016/j.ctim.2019.102229
dc.identifier.volume48en_US
dc.ri.editoaen_US
dc.relation.journalComplementary Therapies in Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster